ABALOS THERAPEUTICS
The company intends to use the funds to advance its arenavirus-based lead candidates towards clinical testing. They will develop the initial product candidates using its proprietary Fast Evolution platform, which will generate virus strains with optimized anti-tumoral properties. These candidates will be selected based on their ability to re-program the immune system to specifically and efficiently eliminate the malignant tumor tissue.
ABALOS THERAPEUTICS
Social Links:
Industry:
Biotechnology
Founded:
2005-01-01
Address:
Essen, Nordrhein-Westfalen, Germany
Country:
Germany
Website Url:
http://www.abalos-tx.com
Total Employee:
11+
Status:
Active
Contact:
+49 201 565 787-00
Email Addresses:
[email protected]
Total Funding:
43 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API WordPress Font Awesome Wordpress Plugins Nginx Euro
Similar Organizations
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Hx Bio Ventures
Hx Bio Ventures investment in Series A - Abalos Therapeutics
coparion
coparion investment in Series A - Abalos Therapeutics
Seventure Partners
Seventure Partners investment in Series A - Abalos Therapeutics
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Series A - Abalos Therapeutics
Ventura BioMed Investors
Ventura BioMed Investors investment in Series A - Abalos Therapeutics
Gruenderfonds Ruhr
Gruenderfonds Ruhr investment in Series A - Abalos Therapeutics
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series A - Abalos Therapeutics
NRW.BANK
NRW.BANK investment in Series A - Abalos Therapeutics
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series A - Abalos Therapeutics
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Series A - Abalos Therapeutics
Official Site Inspections
http://www.abalos-tx.com
- Host name: sh11465.ispgateway.de
- IP address: 92.204.239.155
- Location: Germany
- Latitude: 51.4476
- Longitude: 7.0122
- Timezone: Europe/Berlin
